Anavex Life Sciences (AVXL) Free Cash Flow (QoQ) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.89% |
| Sep 30, 2025 | 30.97% |
| Jun 30, 2025 | -112.84% |
| Mar 31, 2025 | 51.68% |
| Dec 31, 2024 | -82.04% |
| Sep 30, 2024 | -28.53% |
| Jun 30, 2024 | 55.56% |
| Mar 31, 2024 | -59.28% |
| Dec 31, 2023 | -25.12% |
| Sep 30, 2023 | 23.57% |
| Jun 30, 2023 | 9.85% |
| Mar 31, 2023 | -46.51% |
| Dec 31, 2022 | -43.27% |
| Sep 30, 2022 | 42.67% |
| Jun 30, 2022 | 26.83% |
| Mar 31, 2022 | -175.34% |
| Dec 31, 2021 | 54.38% |
| Sep 30, 2021 | -2.05% |
| Jun 30, 2021 | -2.79% |
| Mar 31, 2021 | 7.04% |
| Dec 31, 2020 | -25.85% |
| Sep 30, 2020 | -54.66% |
| Jun 30, 2020 | 23.16% |
| Mar 31, 2020 | 8.07% |
| Dec 31, 2019 | -125.91% |
| Sep 30, 2019 | 66.21% |
| Jun 30, 2019 | -73.18% |
| Mar 31, 2019 | -4.12% |
| Dec 31, 2018 | -2.64% |
| Sep 30, 2018 | -94.10% |
| Jun 30, 2018 | 25.98% |
| Mar 31, 2018 | 22.08% |
| Dec 31, 2017 | -65.16% |
| Sep 30, 2017 | 26.30% |
| Jun 30, 2017 | -326.23% |
| Mar 31, 2017 | 77.87% |
| Dec 31, 2016 | -69.25% |
| Sep 30, 2016 | 16.21% |
| Jun 30, 2016 | -16.89% |
| Mar 31, 2016 | 41.41% |
| Dec 31, 2015 | -126.54% |
| Sep 30, 2015 | -0.21% |
| Jun 30, 2015 | -113.39% |
| Mar 31, 2015 | 3.29% |
| Dec 31, 2014 | 24.46% |
| Sep 30, 2014 | 4.42% |
| Jun 30, 2014 | -176.24% |
| Mar 31, 2014 | 20.53% |
| Dec 31, 2013 | 9.74% |
| Sep 30, 2013 | -1,405.15% |
| Jun 30, 2013 | 75.10% |
| Mar 31, 2013 | 1.73% |
| Dec 31, 2012 | 47.77% |
| Sep 30, 2012 | -5.54% |
| Jun 30, 2012 | -109.05% |
| Mar 31, 2012 | 89.51% |
| Dec 31, 2011 | -17.94% |
| Sep 30, 2011 | 23.50% |
| Jun 30, 2011 | -104.77% |
| Mar 31, 2011 | 45.67% |
| Dec 31, 2010 | 34.84% |